Follow the 엠아이텍 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 엠아이텍 has recorded 3 public disclosures. Market capitalisation: €143.1bn. The latest transaction was reported on 2 April 2026 (Sale). Among the most active insiders: 시너지이노베이션. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
엠아이텍 es una empresa que opera en el sector de la salud y farmacéutico, cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones innovadoras para el campo médico.